![]() |
市場調查報告書
商品編碼
1679304
2030 年甜菊糖配糖體市場預測:按類型、形式、來源、分銷管道、應用和地區進行的全球分析Steviol Glycoside Market Forecasts to 2030 - Global Analysis By Type (Steviolbioside, Stevioside, Rebaudioside A and Other Types), Form, Source, Distribution Channel, Application and By Geography |
根據 Stratistics MRC 的數據,全球甜菊糖配糖體市場預計在 2024 年達到 56.7 億美元,到 2030 年將達到 84.1 億美元,預測期內的複合年成長率為 6.8%。
從甜菊葉中提取的天然甜味劑稱為甜菊糖配糖體。這些配糖體(包括甜菊糖和萊鮑迪苷)使得甜菊糖的甜度比糖高 300 倍。由於其熱量低,因此它是食品和飲料中常用的糖替代品。在體內,甜菊糖配糖體會轉化為甜菊醇並排放,而不會增加血糖值。由於其耐用性和健康益處,它經常用於國際衛生當局核准的低熱量和糖尿病產品。
對天然甜味劑的需求不斷增加
對肥胖和糖尿病的認知不斷增加,促使消費者轉向更健康的糖替代品。食品和飲料製造商使用配糖體來滿足消費者對植物來源、低熱量甜味劑的需求。潔淨標示趨勢和監管部門的核准進一步推動了市場擴張。萃取技術的發展提高了最終產品的品質和價格。此外,該產品在個人護理和藥物領域的廣泛應用也刺激了市場擴張。
供應鍊和原料依賴性
由於甜菊植物的生產來源有限,市場容易受到農業中斷和氣候變遷的影響。物流和運輸問題增加了前置作業時間並影響供應穩定性。對特定地區原料供應的依賴增加了貿易限制和地緣政治不穩定的可能性。原物料價格的波動會影響公司的定價策略和盈利。總的來說,這些變數造成了不確定性,限制了市場成長和投資者信心。
對潔淨標示和有機產品的需求不斷增加
對肥胖和糖尿病的認知不斷增加,促使消費者轉向更健康的糖替代品。食品和飲料製造商使用配糖體來滿足消費者對植物來源、低熱量甜味劑的需求。潔淨標示趨勢和監管部門的核准進一步推動了市場擴張。萃取技術的發展提高了最終產品的品質和價格。此外,個人護理和醫藥產品的使用日益增多也刺激了市場擴張。
監管不確定性和嚴格標準
各國的核准程序不盡相同,減緩了新產品的推出和市場的成長。嚴格的安全和品質標準提高了生產成本,使中小企業難以競爭。可接受的配糖體組成的頻繁變化會給生產者帶來不穩定。冗長的核准流程不利於研發投資。因此,甜菊糖配糖體在食品飲料領域的廣泛應用受到市場擴張放緩的限制。
COVID-19 的影響
COVID-19 疫情影響了供應鏈,減緩了生產速度,並減少了食品和飲料等行業的消費需求,擾亂了配糖體市場。停工和物流挑戰影響了原料的可得性,增加了成本。然而,隨著消費者轉向更健康的天然甜味劑,疫情後需求已經反彈。人們對保健產品中糖替代品的認知不斷提高,這也使市場受益。總體而言,雖然早期的干擾已經減緩了成長,但由於人們健康意識的增強和對潔淨標示產品的偏好,長期前景仍然光明。
預計粉末市場在預測期內將佔據最大佔有率
由於粉末具有高穩定性、長保存期限以及易於加入各種食品和飲料產品的特點,預計在預測期內將佔據最大的市場佔有率。它廣泛用於製藥和營養保健食品行業的無糖配方。消費者對低熱量和天然甜味劑的偏好增加,推動了需求。此外,其成本效益和高效的運輸能力使其成為製造商的首選。不斷增強的健康意識和監管部門的核准進一步推動了市場的成長。
預計預測期內,製藥業將以最高的複合年成長率成長。
由於藥用糖漿、錠劑和保健品中對天然低熱量甜味劑的需求很高,預計預測期內製藥業將出現最高成長率。由於其不產鹼且適合糖尿病患者,因此成為藥物製劑中首選的糖替代品。消費者對健康益處的認知不斷提高以及監管部門的核准進一步推動了它們在藥物配方中的應用。藥品向植物來源成分的轉變將推動市場成長。此外,對甜菊糖配糖體潛在治療效果的持續研究也加強了其在該領域的應用。
在預測期內,由於對天然低熱量甜味劑的需求不斷增加,預計北美將佔據最大的市場佔有率。糖尿病和肥胖症的盛行率不斷上升,促使消費者轉向糖替代品,從而推動食品和飲料中對甜菊糖製品的採用。美國和加拿大是主要市場,這兩個國家的公司專注於產品創新和潔淨標示運動。美國食品藥物管理局(FDA)和加拿大衛生署的監管核准正在進一步加速市場擴張。主要企業包括嘉吉、宜瑞安和PureCircle,它們正在利用萃取技術的進步來提高其產品的品質和甜度。
預計預測期內亞太地區將呈現最高的複合年成長率。這是由於人們的健康意識不斷增強以及對糖替代品的監管支持導致對天然甜味劑的需求不斷成長。中國、印度和日本等國家是主要市場,在食品、飲料和藥品領域的應用正在擴大。機能性食品和飲料產業的成長,加上消費者對低熱量產品的偏好,正在推動需求。此外,提取技術的進步和大公司的投資也有助於推動市場擴張。該地區糖尿病患者的不斷成長進一步增加了對甜菊糖甜味劑的需求。
According to Stratistics MRC, the Global Steviol Glycoside Market is accounted for $5.67 billion in 2024 and is expected to reach $8.41 billion by 2030 growing at a CAGR of 6.8% during the forecast period. Natural sweet substances called steviol glycosides are extracted from the leaves of the Stevia rebaudiana plant. Stevia is up to 300 times sweeter than sugar due to these glycosides, which also include stevioside and rebaudioside. They are a common sugar alternative in foods and drinks since they are low in calories. The body converts steviol glycosides into steviol, which is then eliminated without increasing blood sugar levels. Because of their durability and health advantages, they are frequently used in low-calorie and diabetic-friendly products that have been approved by international health authorities.
Rising demand for natural sweeteners
Growing knowledge of obesity and diabetes is causing consumers to turn to healthier sugar substitutes. Steviol glycosides are being used by food and beverage producers to satisfy consumer demand for plant-based, low-calorie sweeteners. Market expansion is further supported by clean-label trends and regulatory approvals. Technological developments in extraction improve the quality and affordability of the final product. Market expansion is also fuelled by the growing use of personal care and pharmaceutical goods.
Supply chain & raw material dependence
The market is susceptible to agricultural interruptions and climate change due to the limited sources of stevia plant production. Problems with logistics and transportation lengthen lead times, which impacts consistent supply. Reliance on certain areas for raw supplies increases the likelihood of trade restrictions and geopolitical unrest. Changes in raw material prices have an effect on firms' pricing strategies and profitability. All things considered, these variables provide uncertainty, which restricts market growth and investor confidence.
Growing demand for clean-label & organic products
Growing knowledge of obesity and diabetes is causing consumers to turn to healthier sugar substitutes. Steviol glycosides are being used by food and beverage producers to satisfy consumer demand for plant-based, low-calorie sweeteners. Market expansion is further supported by clean-label trends and regulatory approvals. Technological developments in extraction improve the quality and affordability of the final product. Market expansion is also fuelled by the growing use of personal care and pharmaceutical goods.
Regulatory uncertainty & stringent standards
Approval procedures differ per nation, which delays the introduction of new products and the growth of markets. Strict safety and quality standards raise production costs, which makes it harder for small businesses to compete. Producers experience instability as a result of frequent changes in the acceptable glycoside compositions. Investment in R&D is discouraged by lengthy approval processes. Steviol glycosides' broad use in the food and beverage sector is thus constrained by the slowing market expansion.
Covid-19 Impact
The COVID-19 pandemic disrupted the steviol glycoside market by affecting supply chains, delaying production, and reducing consumer demand in sectors like food and beverages. Lockdowns and logistical challenges impacted raw material availability, increasing costs. However, as consumers shifted towards healthier, natural sweeteners, demand rebounded post-pandemic. The market also benefited from increased awareness of sugar alternatives in wellness products. Overall, while initial disruptions slowed growth, the long-term outlook remains positive due to rising health consciousness and clean-label product preferences.
The powder segment is expected to be the largest during the forecast period
The powder segment is expected to account for the largest market share during the forecast period, due to its high stability, longer shelf life, and ease of incorporation into various food and beverage products. It is widely used in the pharmaceutical and nutraceutical industries for sugar-free formulations. The growing consumer preference for low-calorie and natural sweeteners boosts its demand. Additionally, its cost-effectiveness and efficient transportability make it a preferred choice for manufacturers. Increasing health consciousness and regulatory approvals further drive its market growth.
The pharmaceuticals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pharmaceuticals segment is predicted to witness the highest growth rate, due to the high demand for natural, low-calorie sweeteners in medicinal syrups, tablets, and health supplements. Its non-cariogenic and diabetic-friendly properties make it a preferred sugar alternative in pharmaceutical formulations. Rising consumer awareness of health benefits and regulatory approvals further boost its adoption in drug formulations. The shift toward plant-based ingredients in pharmaceuticals enhances market growth. Additionally, ongoing research into steviol glycosides' potential therapeutic benefits strengthens their application in the sector.
During the forecast period, the North America region is expected to hold the largest market share due to increasing demand for natural, low-calorie sweeteners. The rising prevalence of diabetes and obesity has driven consumers toward sugar alternatives, boosting the adoption of stevia-based products in food and beverages. The U.S. and Canada are key markets, with companies focusing on product innovation and clean-label trends. Regulatory approvals from the FDA and Health Canada have further accelerated market expansion. Key players include Cargill, Ingredion, and PureCircle, leveraging advancements in extraction techniques to enhance product quality and sweetness profiles.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rising demand for natural sweeteners, driven by increasing health consciousness and regulatory support for sugar alternatives. Countries like China, India, and Japan are key markets, with expanding applications in food, beverages, and pharmaceuticals. The growth of the functional food and beverage sector, coupled with consumer preference for low-calorie products, is fueling demand. Additionally, advancements in extraction technologies and investments by major players are boosting market expansion. The region's flourishing diabetic population further strengthens the need for stevia-based sweeteners.
Key players in the market
Some of the key players profiled in the Steviol Glycoside Market include Cargill, Incorporated, PureCircle Ltd., Tate & Lyle PLC, GLG Life Tech Corporation, Ingredion Incorporated, Sunwin Stevia International, Inc., Stevia Corp., Morita Kagaku Kogyo Co., Ltd., Zhucheng Haotian Pharm Co., Ltd., Daepyung Co., Ltd., Sunrise Nutrachem Group, Merisant, Evolva Holding SA, SweeGen, Inc., Blue California, Layn Corp., DSM and FUJIFILM Wako Pure Chemical Corporation.
In October 2024, Tate & Lyle announced a strategic partnership with Manus, a bioalternatives scale-up platform, to expand access to natural sugar reduction solutions. The collaboration focused on the large-scale commercialization of stevia Reb M, sourced and manufactured in the Americas.
In August 2024, Tate & Lyle introduced OPTIMISER STEVIA 8.10, a new stevia composition designed to provide a premium flavor profile even at high sugar replacement levels. This product offers a cost-effective and versatile solution for manufacturers seeking natural sweeteners.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.